![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: GDA |
Gene summary for GDA |
![]() |
Gene information | Species | Human | Gene symbol | GDA | Gene ID | 9615 |
Gene name | guanine deaminase | |
Gene Alias | CYPIN | |
Cytomap | 9q21.13 | |
Gene Type | protein-coding | GO ID | GO:0000255 | UniProtAcc | Q9Y2T3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9615 | GDA | HTA11_2487_2000001011 | Human | Colorectum | SER | 6.29e-09 | 8.87e-01 | -0.1808 |
9615 | GDA | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.58e-03 | 2.69e-01 | -0.0811 |
9615 | GDA | HTA11_78_2000001011 | Human | Colorectum | AD | 6.31e-04 | 3.51e-01 | -0.1088 |
9615 | GDA | HTA11_347_2000001011 | Human | Colorectum | AD | 6.06e-04 | 4.83e-01 | -0.1954 |
9615 | GDA | HTA11_2112_2000001011 | Human | Colorectum | SER | 2.70e-02 | 8.18e-01 | -0.2196 |
9615 | GDA | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.34e-03 | 4.75e-01 | -0.059 |
9615 | GDA | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 6.59e-05 | 1.43e+00 | 0.3487 |
9615 | GDA | HTA11_99999965104_69814 | Human | Colorectum | MSS | 3.13e-02 | 2.27e-01 | 0.281 |
9615 | GDA | CRC-1-8810 | Human | Colorectum | CRC | 7.56e-05 | 3.50e-01 | 0.6257 |
9615 | GDA | AEH-subject1 | Human | Endometrium | AEH | 3.00e-11 | 5.37e-01 | -0.3059 |
9615 | GDA | AEH-subject2 | Human | Endometrium | AEH | 9.63e-22 | 7.05e-01 | -0.2525 |
9615 | GDA | AEH-subject3 | Human | Endometrium | AEH | 4.70e-02 | 2.50e-01 | -0.2576 |
9615 | GDA | AEH-subject4 | Human | Endometrium | AEH | 6.96e-08 | 4.00e-01 | -0.2657 |
9615 | GDA | AEH-subject5 | Human | Endometrium | AEH | 4.57e-11 | 6.02e-01 | -0.2953 |
9615 | GDA | EEC-subject2 | Human | Endometrium | EEC | 3.15e-25 | 7.45e-01 | -0.2607 |
9615 | GDA | EEC-subject5 | Human | Endometrium | EEC | 5.10e-13 | 5.55e-01 | -0.249 |
9615 | GDA | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 4.17e-02 | 1.92e-01 | -0.1934 |
9615 | GDA | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 5.00e-11 | 4.51e-01 | -0.1917 |
9615 | GDA | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 5.10e-10 | 4.95e-01 | -0.1916 |
9615 | GDA | GSM6177623_NYU_UCEC3_Vis | Human | Endometrium | EEC | 3.01e-13 | 4.31e-01 | -0.1269 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00482853 | Esophagus | ESCC | organelle fission | 301/8552 | 488/18723 | 4.64e-13 | 2.12e-11 | 301 |
GO:0031668111 | Esophagus | ESCC | cellular response to extracellular stimulus | 168/8552 | 246/18723 | 4.93e-13 | 2.23e-11 | 168 |
GO:0031669110 | Esophagus | ESCC | cellular response to nutrient levels | 148/8552 | 215/18723 | 4.58e-12 | 1.76e-10 | 148 |
GO:0031667111 | Esophagus | ESCC | response to nutrient levels | 289/8552 | 474/18723 | 9.25e-12 | 3.47e-10 | 289 |
GO:000758410 | Esophagus | ESCC | response to nutrient | 114/8552 | 174/18723 | 9.43e-08 | 1.56e-06 | 114 |
GO:00067906 | Esophagus | ESCC | sulfur compound metabolic process | 201/8552 | 339/18723 | 2.64e-07 | 3.94e-06 | 201 |
GO:00482844 | Esophagus | ESCC | organelle fusion | 94/8552 | 141/18723 | 3.72e-07 | 5.16e-06 | 94 |
GO:00065757 | Esophagus | ESCC | cellular modified amino acid metabolic process | 112/8552 | 188/18723 | 8.31e-05 | 6.06e-04 | 112 |
GO:00332734 | Esophagus | ESCC | response to vitamin | 60/8552 | 93/18723 | 1.89e-04 | 1.21e-03 | 60 |
GO:000674912 | Esophagus | ESCC | glutathione metabolic process | 42/8552 | 64/18723 | 1.01e-03 | 5.12e-03 | 42 |
GO:0033280 | Esophagus | ESCC | response to vitamin D | 25/8552 | 35/18723 | 1.82e-03 | 8.35e-03 | 25 |
GO:00080532 | Esophagus | ESCC | mitochondrial fusion | 20/8552 | 27/18723 | 2.61e-03 | 1.11e-02 | 20 |
GO:00316701 | Esophagus | ESCC | cellular response to nutrient | 30/8552 | 45/18723 | 3.63e-03 | 1.48e-02 | 30 |
GO:00325261 | Esophagus | ESCC | response to retinoic acid | 63/8552 | 107/18723 | 4.05e-03 | 1.62e-02 | 63 |
GO:00002662 | Esophagus | ESCC | mitochondrial fission | 28/8552 | 42/18723 | 4.90e-03 | 1.89e-02 | 28 |
GO:00442825 | Liver | NAFLD | small molecule catabolic process | 91/1882 | 376/18723 | 8.96e-16 | 1.31e-12 | 91 |
GO:00194396 | Liver | NAFLD | aromatic compound catabolic process | 102/1882 | 467/18723 | 2.29e-14 | 1.91e-11 | 102 |
GO:19013616 | Liver | NAFLD | organic cyclic compound catabolic process | 105/1882 | 495/18723 | 7.04e-14 | 5.15e-11 | 105 |
GO:00442707 | Liver | NAFLD | cellular nitrogen compound catabolic process | 93/1882 | 451/18723 | 1.04e-11 | 4.34e-09 | 93 |
GO:00467006 | Liver | NAFLD | heterocycle catabolic process | 92/1882 | 445/18723 | 1.16e-11 | 4.52e-09 | 92 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa01232 | Liver | Cirrhotic | Nucleotide metabolism | 39/2530 | 85/8465 | 1.27e-03 | 6.73e-03 | 4.15e-03 | 39 |
hsa012321 | Liver | Cirrhotic | Nucleotide metabolism | 39/2530 | 85/8465 | 1.27e-03 | 6.73e-03 | 4.15e-03 | 39 |
hsa012322 | Liver | HCC | Nucleotide metabolism | 59/4020 | 85/8465 | 3.30e-05 | 1.88e-04 | 1.04e-04 | 59 |
hsa012323 | Liver | HCC | Nucleotide metabolism | 59/4020 | 85/8465 | 3.30e-05 | 1.88e-04 | 1.04e-04 | 59 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GDA | SNV | Missense_Mutation | novel | c.311N>G | p.Thr104Ser | p.T104S | Q9Y2T3 | protein_coding | tolerated(0.24) | benign(0.001) | TCGA-A2-A0D0-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD |
GDA | SNV | Missense_Mutation | c.666N>C | p.Leu222Phe | p.L222F | Q9Y2T3 | protein_coding | deleterious(0) | possibly_damaging(0.907) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
GDA | SNV | Missense_Mutation | novel | c.448N>C | p.Ser150Pro | p.S150P | Q9Y2T3 | protein_coding | deleterious(0.02) | possibly_damaging(0.749) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GDA | SNV | Missense_Mutation | c.352N>A | p.Asp118Asn | p.D118N | Q9Y2T3 | protein_coding | tolerated(0.11) | benign(0.006) | TCGA-EW-A1J5-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
GDA | SNV | Missense_Mutation | rs748443792 | c.895N>A | p.Ala299Thr | p.A299T | Q9Y2T3 | protein_coding | tolerated(0.19) | possibly_damaging(0.446) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
GDA | SNV | Missense_Mutation | c.574G>A | p.Glu192Lys | p.E192K | Q9Y2T3 | protein_coding | tolerated(0.61) | benign(0.001) | TCGA-C5-A7UH-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
GDA | SNV | Missense_Mutation | c.361N>A | p.Glu121Lys | p.E121K | Q9Y2T3 | protein_coding | tolerated(0.39) | benign(0.023) | TCGA-EK-A2R8-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
GDA | SNV | Missense_Mutation | c.148N>G | p.Gln50Glu | p.Q50E | Q9Y2T3 | protein_coding | tolerated(0.37) | benign(0) | TCGA-EK-A3GK-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
GDA | SNV | Missense_Mutation | c.738N>G | p.Asp246Glu | p.D246E | Q9Y2T3 | protein_coding | tolerated(0.69) | benign(0) | TCGA-CM-6676-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
GDA | SNV | Missense_Mutation | c.74C>A | p.Pro25His | p.P25H | Q9Y2T3 | protein_coding | tolerated(0.22) | benign(0.029) | TCGA-G4-6309-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | xeloda | PD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
9615 | GDA | ENZYME | NSC-7861 | 7-METHYLXANTHINE | 20716488 | |
9615 | GDA | ENZYME | 8-AZAGUANINE | 8-AZAGUANINE | 7384171 | |
9615 | GDA | ENZYME | THIOGUANINE | THIOGUANINE | 7384171 |
Page: 1 |